Christopher J. DelOrefice's Insider Trades & SAST Disclosures

Christopher J. DelOrefice's most recent trade in Ulta Beauty Inc was a trade of 14,363 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 31, 2026.

Share

Note

This is a custom search result for pattern Christopher J. DelOrefice.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Ulta Beauty	Christopher J. DelOrefice	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2026	14,363	14,363	-		-	Stock Option (right to buy)
Ulta Beauty	Christopher J. DelOrefice	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2026	4,219	9,693 (0%)	0%		0	Common Stock
Ulta Beauty	Christopher J. DelOrefice	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2025	3,649	5,474 (0%)	0%		0	Common Stock
Ulta Beauty	Christopher J. DelOrefice	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2025	1,825	1,825 (0%)	0%		0	Common Stock
Becton, Dickinson and Co.	Christopher J. DelOrefice	EVP & Chief Financial Officer		26 Nov 2025	6,006	27,227 (0%)	0%		0	Common Stock
Becton, Dickinson and Co.	Christopher J. DelOrefice	EVP & Chief Financial Officer		26 Nov 2025	4,245	22,982 (0%)	0%		0	Common Stock
ResMed Dividend	Christopher J. DelOrefice	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Nov 2025	1,073	2,423 (0%)	0%		0	ResMed Common Stock
Becton, Dickinson and Co.	Christopher J. DelOrefice	EVP & Chief Financial Officer		01 Sep 2025	278	21,221 (0%)	0%		0	Common Stock
Becton, Dickinson and Co.	Christopher J. DelOrefice	EVP & Chief Financial Officer		26 Nov 2024	19,138	19,138	-		-	Stock Appreciation Rights
Becton, Dickinson and Co.	Christopher J. DelOrefice	EVP & Chief Financial Officer		26 Nov 2024	9,015	26,691 (0%)	0%		0	Common Stock
Becton, Dickinson and Co.	Christopher J. DelOrefice	EVP & Chief Financial Officer		26 Nov 2024	5,192	21,499 (0%)	0%		0	Common Stock
Becton, Dickinson and Co.	Christopher J. DelOrefice	EVP & Chief Financial Officer		26 Nov 2024	4,884	17,676 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades